TriSalus Life Sciences, Inc. TLSI EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from TriSalus Life Sciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s EBITDA margin?
- TriSalus Life Sciences, Inc. (TLSI) reported EBITDA margin of -61.1% in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s EBITDA margin changed year-over-year?
- TriSalus Life Sciences, Inc.'s EBITDA margin increased by 36.8% year-over-year, from -96.7% to -61.1%.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s EBITDA margin?
- Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s EBITDA margin has grown at a -55.2% compound annual growth rate (CAGR), from -290.3% to -58.3%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.